GlassScriptPhysician profile
Matthew D Daugherty
NPI 1245510932
$39,026.34
in general payments reported to CMS, 2019-2025
15 companies · $23.24 in 2025
The $23.24 reported for 2025 was less than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $113 · 2021: $136 · 2022: $7,735 · 2023: $200 · 2024: $31K · 2025: $23.24.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Debt Forgiveness: $31K · Food and Beverage: $243.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Debt Forgiveness | $30,800.00 |
| Food and Beverage | $242.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convatec INC. | $30,800.00 | 2024 | |
| Triad Life Sciences INC. | $7,734.65 | 2022 | |
| Vaporox, INC. | $168.47 | 2023 | Vht-200 Wound Treatment System |
| Organogenesis INC. | $107.01 | 2021 | |
| Wright Medical Technology, INC. | $33.75 | 2019 | |
| Sanara Medtech INC. | $29.06 | 2021 | |
| Biowound Solutions, INC. | $23.24 | 2025 | Bio-Connekt |
| Stryker Corporation | $19.22 | 2024 | Ortholoc 3di Crosscheck |
| Pylant Medical | $17.46 | 2019 | |
| Bioventus LLC | $17.04 | 2023 | |
| Tactile Systems Technology INC | $16.83 | 2019 | |
| Genentech USA, INC. | $15.70 | 2019 | |
| Smith+Nephew, INC. | $15.66 | 2019 | |
| Nevro Corp. | $14.96 | 2023 | Senza |
| Melinta Therapeutics, LLC | $13.29 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Daugherty listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.